Additionally, the IGF-1R inhibitor PQIP diminishes the breast cancer cell-induced osteolysis in a bone metastasis mouse model by inhibiting the IGF-1/IGF-1R/AKT axis-dependent osteoclast formation [72]. This evidence concerns the gene IGF1 and breast carcinoma.